Correction: Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials

Detalles Bibliográficos
Autores principales: Chu, Xianjing, Tian, Wentao, Wang, Ziqi, Zhang, Jing, Zhou, Rongrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294354/
https://www.ncbi.nlm.nih.gov/pubmed/37370104
http://dx.doi.org/10.1186/s12943-023-01812-z
_version_ 1785063177421062144
author Chu, Xianjing
Tian, Wentao
Wang, Ziqi
Zhang, Jing
Zhou, Rongrong
author_facet Chu, Xianjing
Tian, Wentao
Wang, Ziqi
Zhang, Jing
Zhou, Rongrong
author_sort Chu, Xianjing
collection PubMed
description
format Online
Article
Text
id pubmed-10294354
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102943542023-06-28 Correction: Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials Chu, Xianjing Tian, Wentao Wang, Ziqi Zhang, Jing Zhou, Rongrong Mol Cancer Correction BioMed Central 2023-06-27 /pmc/articles/PMC10294354/ /pubmed/37370104 http://dx.doi.org/10.1186/s12943-023-01812-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Chu, Xianjing
Tian, Wentao
Wang, Ziqi
Zhang, Jing
Zhou, Rongrong
Correction: Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials
title Correction: Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials
title_full Correction: Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials
title_fullStr Correction: Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials
title_full_unstemmed Correction: Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials
title_short Correction: Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials
title_sort correction: co-inhibition of tigit and pd-1/pd-l1 in cancer immunotherapy: mechanisms and clinical trials
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294354/
https://www.ncbi.nlm.nih.gov/pubmed/37370104
http://dx.doi.org/10.1186/s12943-023-01812-z
work_keys_str_mv AT chuxianjing correctioncoinhibitionoftigitandpd1pdl1incancerimmunotherapymechanismsandclinicaltrials
AT tianwentao correctioncoinhibitionoftigitandpd1pdl1incancerimmunotherapymechanismsandclinicaltrials
AT wangziqi correctioncoinhibitionoftigitandpd1pdl1incancerimmunotherapymechanismsandclinicaltrials
AT zhangjing correctioncoinhibitionoftigitandpd1pdl1incancerimmunotherapymechanismsandclinicaltrials
AT zhourongrong correctioncoinhibitionoftigitandpd1pdl1incancerimmunotherapymechanismsandclinicaltrials

Ejemplares similares